SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

WHO concludes Pre-Qualification of Pentavalent Vaccine Easyfive-TT of Panacea Biotec

19 Sep 2013 Evaluate

World Health Organization (WHO) has completed the evaluation process of Pre-qualification (PQ) of its Pentavalent vaccine Easyfive-TT (DTwP-HepB-Hib). WHO has informed that they are initiating the arrangements for PQ, and has informed the UNICEF (the procurement agency for Global markets) of the positive outcome of the evaluation process. WHO will be issuing the letter to UNICEF informing the PQ of EasyfiveTT mono (1 dose) and multi-dose (10 dose) presentations and the details of PQ will also be published on WHO webpage soon. The Company has successfully completed the audit of its Lalru and Baddi facilities, conducted by WHO team from February, 28 till March, 1 2013.

The Company is preparing itself to supply Easyfive-TT vaccine (pentavalent vaccine that protects against five diseases - Diphtheria, Tetanus, Pertusis, Hepatitis B and Haemophilus influenzae type b (Hib) of early childhood) to UNICEF and other international agencies involved in procurement of vaccines at Global as well as National levels in various countries.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

342.05 -15.95 (-4.46%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×